⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
REGN News
Regeneron Pharmaceuticals Inc
Form 8-K
sec.gov
REGN
SAS Innovate 2026 to feature new health care and life sciences AI capabilities and real-world use cases
prnewswire.com
JNJ
AZN
GILD
REGN
SNY
IQV
OGN
PFE
ABBV
ELV
CI
TriNetX arbeitet mit Regeneron zusammen, um Zugang zu anonymisierten elektronischen Patientenakten von 300 Millionen Patienten zu erhalten und damit die Forschung und Produktentwicklung in den Bereichen Biowissenschaften und digitale Gesundheitslösungen
prnewswire.com
REGN
Centri Announces Panel Topics and Featured Programming for Second Annual Capital Conference at Nasdaq on April 14
accessnewswire.com
NDAQ
DFIN
PTGX
STRL
TNDM
AXSM
CSTL
CYTK
GILD
INSM
KODK
NBIX
OCGN
REGN
SRPT
VRTX
XBIT
AMZN
GOOGL
MSFT
NVDA
IBM
ORGN
BWEN
CCJ
EXC
NEE
SO
UTL
XOM
BALY
OXY
PBF
CHRD
AX
BAC
MAXN
PHIO
KZR
SMX
DUOT
COIN
EHTH
TriNetX colabora con Regeneron para acceder a registros electrónicos de salud anonimizados USA - español USA - English India - English USA - Français Japan - Japanese
prnewswire.com
REGN
TriNetX collabore avec Regeneron pour accéder aux dossiers médicaux électroniques dépersonnalisés de 300 millions de patients afin de stimuler la recherche et le développement de produits dans le domaine des sciences de la vie et des solutions de santé
prnewswire.com
REGN
TriNetX Collaborates with Regeneron to Access De-Identified Electronic Health Records of 300 Million Patients to Drive Research and Product Development in Life Sciences and Digital Health Solutions USA - English India - English
prnewswire.com
REGN
Regeneron Collaborates with TriNetX to Access De-Identified Electronic Health Records of 300 Million Patients to Drive Research and Product Development in Life Sciences and Digital Health Solutions
globenewswire.com
REGN
EYLEA HD® (aflibercept) Approved by FDA as First and Only Injectable Anti-VEGF with Dosing Intervals Up to 5 Months for Wet Age-related Macular Degeneration (wAMD) and Diabetic Macular Edema (DME)
globenewswire.com
REGN
Programmed Death (PD)-1 Non-Small Cell Lung Cancer Market Intelligence Report 2026-2030: Industry Growth Driven by Personalized Treatment Adoption
globenewswire.com
MRK
REGN
BNTX